Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

45.68
-1.8700-3.93%
Volume:1.08M
Turnover:50.01M
Market Cap:4.38B
PE:-7.06
High:47.83
Open:47.24
Low:45.35
Close:47.55
52wk High:78.48
52wk Low:30.04
Shares:95.99M
Float Shares:90.53M
Volume Ratio:0.79
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4700
EPS(LYR):-6.4700
ROE:-30.18%
ROA:-15.76%
PB:2.28
PE(LYR):-7.06

Loading ...

Sep 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 27, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 27, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2020

Major Issues Report

8-K - Current report
Jul 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 02, 2020

Major Issues Report

8-K - Current report
Jun 12, 2020

Major Issues Report

8-K - Current report
Jun 12, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Apr 28, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 28, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 31, 2020

Major Issues Report

Current report, item 8.01
Feb 26, 2020

Major Issues Report

8-K - Current report
Feb 14, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals